Hereditary angioedema (hae) Trials in Scottsdale, United States
Conditions / Hereditary angioedema (hae) / Scottsdale, United States
Hereditary angioedema (hae) is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02741596 | Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE | COMPLETED | PHASE3 |
| NCT00457015 | Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) | COMPLETED | PHASE3 |
| NCT06842823 | A Study of Navenibart in Participants With Hereditary Angioedema | RECRUITING | PHASE3 |
| NCT00456508 | Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) | COMPLETED | PHASE3 |
| NCT03845400 | A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America | COMPLETED | — |
| NCT01756157 | Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks | COMPLETED | PHASE2 |
| NCT02584959 | Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema | COMPLETED | PHASE3 |
| NCT05396105 | Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema | ENROLLING_BY_INVITATION | PHASE2/PHASE3 |
| NCT04583007 | Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults | NO_LONGER_AVAILABLE | — |
| NCT02586805 | Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE | COMPLETED | PHASE3 |